Upload

Loading...

ISSCR 2012 -- Leaving Nothing to Chance

562 views

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jul 25, 2012

Learn more at http://www.invitrogen.com/site/us/en/...

Induced pluripotent stem cells (ipscs) offer a new cellular window into disease and therapy. Traditional reprogramming and transgenic methods can disrupt gene function through random DNA insertion. Dr. Mark Tomishima, of the Sloan Kettering Institute Stem Cell Research Facility, discusses the work of his lab in evolving their methods to reprogram cells using Sendai viral vectors that do not alter the genome. They now also target transgene insertion through the use of zinc finger nucleases. These two technologies allow the production of engineered iPSC lines that lack randomly inserted DNA.

  • Category

  • License

    • Standard YouTube License

Loading...

When autoplay is enabled, a suggested video will automatically play next.

Up next


to add this to Watch Later

Add to

Loading playlists...